AbbVie Inc vs Agora Inc — how do they compare? AbbVie Inc trades at $249.84 (market cap $441.94B), while Agora Inc trades at $4.7 (market cap $394.85M). The key difference: AbbVie Inc is far larger — about 1119.3× Agora Inc's market cap, and AbbVie Inc pays a 2.77% dividend while Agora Inc pays none. Which is the better fit depends on your goals.
| ABBV | API | |
|---|---|---|
Market Cap | $441.94B | $394.85M |
Sector | Health | Technology |
52-Week High | $263.58 | $5.26 |
52-Week Low | $197.38 | $3.24 |
Enterprise Value | $506.19B | $147.83M |
Dividend Yield | 2.77% | — |
Signals from Pluang's Aura AI — not financial advice
ABBV trades at $247.91, up 0.76% today, with a bullish technical signal supported by moving averages and oversold RSI levels. The company reported Q2 2026 EPS of $3.65, beating expectations, and maintains strong profitability with a 71.48% gross margin. Recent news highlights positive Phase 2 data for ELAHERE in ovarian cancer, reinforcing growth prospects beyond Humira's patent expiry.
Outlook is positive with analyst consensus target of $278.69, though high P/E of 70.05 and debt levels pose valuation and financial risks. Revenue growth driven by Skyrizi and Rinvoq offsets competitive pressures, but patent cliffs in the 2030s require monitoring. The stock offers dividend appeal with a $1.73 payout scheduled for August 2026.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
AbbVie is a pharmaceutical company with a strong exposure to immunology and oncology. The firm's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.
Read more on ABBV →Agora Inc provides real-time communication solutions. The company offers real-time video calling, voice calling, live audio and video streaming, recording, and real-time messaging. It serves the gaming, retail, and education industries. The company operates in the People's Republic of China and the United States of America and the majority of its revenue is derived from the People's Republic of China.
Read more on API →